Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Virus-like particle vaccines for mucosal immunization

M K Estes1, J M Ball, S E Crawford

  • 1Division of Molecular Virology, Department of Medicine, Baylor College of Medicine, Houston, Texas 77030, USA.

Advances in Experimental Medicine and Biology
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MASSIVE PULMONARY EMBOLISM: A RARE PRESENTATION OF ACUTE HIV-1 INFECTION.

The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society·2016
Same author

Rituximab.

Clinical journal of oncology nursing·2002
Same author

Marked differences in the frequency of microsatellite instability in gastric cancer from different countries.

The American journal of gastroenterology·1999
Same author

The differential diagnosis of early gastric mucosa-associated lymphoma: polymerase chain reaction and paraffin section immunophenotyping.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·1999
Same author

Metronidazole and clarithromycin resistance amongst Helicobacter pylori isolates from a large metropolitan hospital in the United States.

International journal of antimicrobial agents·1999
Same author

CagA status and gastric cancer unreliable serological tests produce unreliable data.

Gastroenterology·1999

Researchers created virus-like particles (VLPs) from gastrointestinal viruses for oral vaccine development. These stable VLPs show promise for delivering antigens or drugs to the gut.

Area of Science:

  • Virology
  • Immunology
  • Vaccine Development

Background:

  • Gastrointestinal viruses are suitable models for studying oral antigen delivery and oral vaccines.
  • Understanding immune responses to oral antigen delivery is crucial for vaccine design.
  • Nonreplicating virus-like particles (VLPs) offer a safe platform for vaccine research.

Purpose of the Study:

  • To produce nonreplicating virus-like particles (VLPs) from rotavirus and Norwalk virus using recombinant DNA technology.
  • To evaluate the potential of these VLPs as subunit vaccines for oral or parenteral delivery.
  • To explore the utility of VLPs as carriers for foreign epitopes or gastrointestinal-targeted drugs.

Main Methods:

  • Recombinant DNA techniques were employed to generate self-assembled VLPs.

Related Experiment Videos

  • VLPs were produced in insect cells.
  • Morphological and antigenic similarities to native viruses were assessed.

    • Main Results:

    • Nonreplicating VLPs were successfully produced from rotavirus and Norwalk virus.
    • These VLPs are morphologically and antigenically similar to their native counterparts.
    • The VLPs exhibit stability, a key feature for vaccine applications.

    Conclusions:

    • Virus-like particles derived from gastrointestinal viruses are promising candidates for subunit vaccines.
    • VLPs can be delivered parenterally or orally, offering flexibility in vaccine strategies.
    • The potential of VLPs extends to use as carriers for therapeutic agents or foreign antigens.